SELLAS Life Sciences Group, Inc. (SLS) Net margin 2020–2022
SELLAS Life Sciences Group, Inc. (SLS) net profit margin by fiscal year — reported net income divided by reported revenue.
-4130.1%FY2022 · since FY2020: -881.9% → -4130.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -4130.1% | -3857.7 pp |
| FY2021 | -272.4% | +609.6 pp |
| FY2020 | -881.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice